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Abstract 
Supramolecular chemistry offers an exciting opportunity to assemble materials with molecular 
precision. However, there remains an unmet need to turn molecular self-assembly into functional 
materials and devices. Harnessing the inherent properties of both disordered proteins and graphene 
oxide (GO), we report a disordered protein-GO co-assembling system that through a diffusion-reaction 
process and disorder-to-order transitions generates hierarchically organized materials that exhibit high 
stability and access to non-equilibrium on demand. We use experimental approaches and molecular 
dynamics simulations to describe the underlying molecular mechanism of formation and establish key 
rules for its design and regulation. Through rapid prototyping techniques, we demonstrate the system’s 
capacity to be controlled with spatio-temporal precision into well-defined capillary-like fluidic 
microstructures with a high level of biocompatibility and, importantly, the capacity to withstand flow. 
Our study presents an innovative approach to transform rational supramolecular design into functional 
engineering with potential widespread use in microfluidic systems and organ-on-a-chip platforms. 
 
Introduction 
There is an increasing interest to generate materials with bioinspired functions1 such as the capacity to 
grow2, self-replicate3, or controllably respond to specific stimuli4. Biological materials acquire most of 
these functionalities as a consequence of their ability to self-assemble various types of building blocks 
at multiple length scales. Engineering materials in this manner provides an opportunity to take 
advantage of the individual building-blocks while enabling emergent properties as a result of their 
interactions5,6. Consequently, multicomponent self-assembly represents an attractive route to develop 
more complex materials7 with enhanced modularity and tuneability of properties8,9 such as structural 
hierarchy10, adhesion11, electrical conductivity12, or the capacity to grow13.  
 
Proteins are the most functional building-blocks of organisms14 and, as such, have been thoroughly 
explored to engineer intelligent materials15–17. However, new discoveries are shaping our understanding 
of how proteins function and providing new insights for their utilisation. For example, there is 
increasing evidence that both ordered (i.e. β-sheet, α-helix) and disordered (i.e. random coil) regions of 
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proteins play a role in their functionality18 and growing acceptance that this functionality is regulated 
by their interaction with other molecules19. Based on these principles, proteins are emerging as dynamic 
building blocks of multicomponent systems to engineer intelligent materials. We have recently reported 
on the possibility to exploit the disordered nature of elastin-like recombinamers (ELRs) to modulate 
their conformation and generate dynamic13 or hierarchically mineralizing20 materials. ELRs, also known 
as the recombinantly produced elastin-like polypeptides, are based on the natural elastin motif Val-Pro-
Gly-X-Gly (VPGXG), where X could be any amino acid apart from proline21. These molecules exhibit 
a reversible-phase transition with a change in temperature and have been used to create biocompatible 
materials22. 
 
Multicomponent self-assembly also offers a unique opportunity to engineer complex hybrid systems. 
In particular, the controlled incorporation of graphene as a building-block could lead to the design of 
new biomaterials that benefit from its distinctive two-dimensional (2D) structure and outstanding 
electronic, thermal, and mechanical properties23–25. Towards this goal, graphene and its derivatives have 
been modified with biomacromolecules26 such as DNA27, proteins28, and biopolymers29 and used in, for 
example, implants and scaffolds for cell culture and regenerative medicine30,31. Furthermore, graphene 
oxide (GO) is gaining significant interest and being used instead of graphene given its rich oxygen-
containing functional groups (hydroxyl, epoxy, carbonyl, and carboxyl), which facilitate designed 
interactions with different molecules. However, both graphene and GO exhibit key limitations such as 
dose-dependent toxicity and issues associated with hierarchical organisation and the ability to generate 
uniform and stable structures24–26. 
 
Material platforms that exploit the functionalities of both proteins and GO and enable their multiscale 
organization offer exciting possibilities for the engineering of advanced materials. We report a 
hierarchical self-assembling system that takes advantage of protein disorder-to-order transitions and 
supramolecular protein-GO interactions to enable both stable structures and access to non-equilibrium 
with spatial control to design functional materials and devices. Experimental approaches and molecular 
dynamics (MD) simulations were used to elucidate the underlying molecular mechanism and develop 
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rules for its use. We show that the material can be combined with rapid prototyping techniques to 
assemble well-defined tubular microstructures embedded with cells and into fluidic devices. The study 
introduces an innovative way to biofabricate by self-assembly complex and functional devices such as 
microfluidic systems or organ-on-a-chip devices. 
 
Results 
System rationale  
Previous studies have demonstrated the possibility to co-assemble peptides with large macromolecules 
to generate hierarchical membranes at a liquid-liquid interface10,13. These systems rely on both 
molecular interactions such as electrostatic and hydrophobic forces between the two components as 
well as their respective individual properties such as molecular weight, charge, and 3D conformation. 
In particular, by co-assembling ELRs and peptide amphiphiles (PAs), we have previously reported on 
a diffusion-reaction mechanism that relies on PA diffusion to give rise to a multilayer membrane that 
can access non-equilibrium13. However, this material is fragile and can only be assembled in and is 
stable under a narrow window of environmental conditions (pH, temperature, salt concentration), which 
limits its functionality and widespread use. Giving the need for multicomponent approaches that can 
turn molecular design into functional systems1, we envision the possibility to exploit the inherent 
properties of GO to work synergistically with disordered proteins to create materials with both emergent 
properties and functionality. Specifically, we reasoned that, unlike the PAs, the GO lamella 
conformation in aqueous environments32 would provide a supramolecular framework with high surface 
area for ELR interaction, reaching a level of integration far beyond that of the ELR-PA system. 
Furthermore, the GO’s flat-sheet organization at air-liquid interfaces33 would facilitate the generation 
of a diffusion-reaction process that takes advantage of the disordered nature of ELRs to diffuse, conform, 
and integrate with GO, generating a hierarchical process of assembly that can be manipulated on 
demand. In this way, we hypothesized that the co-assembly of GO and ELRs would lead to a robust 
supramolecular system where both strong molecular interactions and controllable access to non-
equilibrium would lead to new materials with enhanced complexity and functionalities. 
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Materials rationale  
We used GO sheets of two different average lateral sizes including larger GO (GO-L) measuring 10.5 
± 4.5 µm and smaller GO (GO-S) of 2.3 ± 0.9 µm, both exhibiting a typical hydrophobic surface and 
negatively charged carboxylic groups on their periphery (Fig. 1b and Supplementary Figure 1). We 
chose ELRs as the protein component because of their modular and disordered nature34 and the 
possibility to exhibit different molecular conformations at different temperatures35. The ELK1 sequence 
(Fig. 1a) is a 51.9 kDa molecule consisting of 24 repeats of a single block made of four hydrophobic 
pentapeptides (VPGIG) and a positively charged (VPGKG) one. This relatively simple molecular 
design offers an accessible transition temperature (Tt) of 30 °C (at 2% ELK1 in MilliQ water) with 
clearly different ELR conformations above or below it, as well as medium molecular weight to enable 
both cooperative interactions between its charged and hydrophobic segments as well as with the anionic 
edge and hydrophobic surface of the GO (Fig. 1c). ELRs with similar molecular weight but different 
levels of charge and hydrophobicity (Fig. 1a), as well as a single repeat of an individual block of each 
of these three ELRs, were used as controls (Supplementary Figure 2, 3, and 4).  
 
Co-assembly 
When an ELK1 solution at its transition temperature (30 °C) is immersed in a larger volume of a GO 
solution, a multi-layered membrane of up to 50 µm in thickness develops at the interface around the 
immersed drop maintaining both solutions separated (Fig. 2a and Supplementary Movie 1). This 
membrane consists of layers made from both GO sheets and ELK1 (Fig. 2b, confocal), with GO sheets 
being present throughout the cross-section of the membrane (Fig. 2b, SEM) and ELK1 gradually 
decreasing in concentration from the inside (ELK1 side) to the outside (GO side) of the membrane (Fig. 
2c and Supplementary Figure 5). Multi-layered structures are known to emerge from diffusion-reaction 
mechanisms36. We have previously demonstrated that co-assembling PAs with ELRs, it is possible to 
trigger a diffusion-reaction mechanism, which generates multi-layered membranes capable of 
exhibiting dynamic properties13. Similarly, by touching any surface within the first few seconds of 
formation, the ELK1-GO membrane adheres, spontaneously and reproducibly opens, and can be 
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manipulated to grow into tubular structures with spatiotemporal control (Fig. 2a, 2d, and Supplementary 
Movie 2). However, in this case, the underlying ELR-GO mechanism of interaction and supramolecular 
assembly lead to the growth of a material with remarkably enhanced properties. 
 
Material structure, properties, and biofabrication of devices 
First, the ELK1-GO membrane is both dynamic and highly stable, permitting controlled anisotropic 
growth of tubular geometries that exhibit no apparent effects on their multi-layered structure when the 
temperature drops below (down to 4 °C) or raises above (up to 70 °C) the Tt of ELK1. This enhanced 
stability is also evidenced by the capability to co-assemble capillary-like structures down to ~50 µm in 
internal diameter, defined by the size of the injecting tip. Moreover, the system also enables the capacity 
to decrease the thickness of the wall down to ~10 µm, achieved by removing the GO solution in order 
to stop the assembly after ~2 min (Fig. 2e). While smaller diameters may be possible by using smaller 
tips, wall-thicknesses below ~10 µm were found to be too fragile to be manipulated. In addition, these 
structures can be grown as tubular bridges between gaps by simply touching, adhering, opening, and 
sealing to a surface soon after co-assembly and continuing injecting ELK1 solution into the GO solution 
until the next surface is touched (Fig. 2f and Supplementary Movie 3). Moreover, the system works in 
salt-containing solutions such as cell culture media, which enables co-assembly and growth of capillary-
like structures in the presence of cells, resulting in structures comprising cells embedded within and on 
the wall of the tube (Fig. 2g). Furthermore, given this versatility and robustness, we demonstrated the 
possibility to use rapid prototyping techniques to guide the co-assembly process using an extrusion-
based 3-D printer to print the ELK1 solution within a GO solution (Supplementary Movie 4), generating 
fluidic devices containing high-aspect ratio tubular structures of different internal diameters and 
comprising curves (Fig. 2h, 2i and Supplementary Movie 5), angles of different sizes (Fig. 2h and 2i), 
and bifurcations (Fig. 2h, 2k and Supplementary Movie 6). The fluidic devices were able to withstand 
aqueous flows of up to 12.5 mL/min for at least 24 hours and within 60 min of formation 
(Supplementary Movie 7 and 8). The highest flows would generate 0.26 N/m2 shear stress, which is 
within the range of mean shear stress values observed in common carotid arteries (0.7 N/m2)37. 
Altogether, these capabilities suggest that the mechanism of formation exhibits both strong ELK1-GO 
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interactions at the molecular scale and integrated organization at higher size scales (Supplementary 
Figure 6 (ELK1)). 
 
Underlying molecular mechanism of assembly: ELK1-GO molecular interactions  
We first tested the presence of both electrostatic and hydrophobic forces by quantifying ELK-GO 
binding constants using ELRs with varying levels of charge and hydrophobicity. Tubes formed on 
application of ELK1 and ELK3 but not ELK0, confirming the need for electrostatic forces for its 
assembly. Interestingly, the highest binding constant (Ka), calculated by fluorescence emission titration, 
was obtained with ELK1 (1.3106) compared to ELK0 (7.2104) and ELK3 (3.2105) (Fig. 3a, 
Supplementary Figure 6b and 6c). Using this method, we also found that the optimum ELK1-GO 
concentration ratio to maximize the interaction between them is 15-40 (Supplementary Figure 7). 
Therefore, keeping the ELK1 concentration at 2%, we developed tubes using GO concentrations 
between 0.05% (corresponding to an ELK1-GO ratio of 40) and 0.15% (corresponding to an ELK1-GO 
ratio of 15), and, as expected, qualitatively found that the best-defined and most robust tubes were made 
within this range (Fig. 3b). To quantify and identify the best ELK1-GO combination, we used an 
established nanotensile test38 on tubes made of 2% ELK1 and increasing concentrations of GO (0.05%, 
0.10%, 0.15%) (Supplementary Section 14). As expected, the strength, the strain at break, and the 
toughness modulus increased on tubes formed with increasing concentrations of GO (Fig. 3c, table). 
However, based on a Weibull statistical distribution, the results revealed that the elastic modulus was 
highest on tubes fabricated with 0.10% GO (212.90 - 247.15 kPa) compared to 0.05% (128.78 - 147.37 
kPa) and 0.15% (159.57 - 208.16 kPa). This result is also visible from the stress-strain curves of the 
ELK1-GO (Fig. 3c, graph), where the samples made with 0.1% GO show a steeper slope, meaning that 
the material is stiffer.  
 
In order to further investigate the role of electrostatic interactions, we formed tubes with ELR and GO 
solutions at varying pHs and again found that more robust membranes formed when the charge 
difference between both components was marginal (Fig. 3d and 3e). These results suggest that optimum 
co-assembly does not solely depend on strong electrostatic forces but rather on a synergistic effect from 
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different factors that we speculate to be electrostatic and hydrophobic forces, H-bonding, and 3D 
conformation. To confirm this premise, we first synthesized a single repeat of each individual ELR 
block. Using CD and MD simulations, we verified that these shorter molecules did not exhibit a Tt but 
have similar secondary structure with large amounts of random coil in aqueous environments 
(Supplementary Figure 8). Upon mixing with GO, all three single repeat peptides exhibited similar 
levels of interaction as evidenced by calculation of the binding constant based on fluorescence emission 
titration (Supplementary Figure 9). To further dissect the nature of the initial ELK1-GO interactions, 
we performed MD simulations at 30 °C and found that H-bonding between the ELK1 and GO plays a 
role and that these interactions can come from both the linear side chain of lysine and the backbone of 
the peptide (Supplementary Section 18). However, in addition to these ELK1-GO molecular 
interactions, we hypothesize that the 3D conformation of the full-length ELK1 protein and its ability to 
cooperatively interact with the GO lamellae play a key role in the formation of the system. To test this 
hypothesis, and taking advantage of the ELR’s capacity to change its conformation at different 
temperatures (Fig. 3f, graph, Supplementary Figure 10 and Supplementary Figure 12), we assembled 
tubes using GO and ELK1 (2% wt) at either below (4 °C), above (45 °C), or the ELK1’s Tt (30 °C) 
(Fig. 3f). While tubes formed at all temperatures, they were more robust and exhibited better-defined 
multilayers (Supplementary Figure 11e) and tubular geometry (Fig. 3f, images) at 30 °C, suggesting 
stronger interactions at this temperature. This enhanced interaction was also investigate by DLS, which 
revealed the presence of larger ELK1-GO aggregates at 30 °C compared to 4 °C and 45 °C (Fig. 3g) 
and further confirm that the 3D conformation of ELK1 at the different temperatures plays a key role in 
its interaction with the GO lamellae, which would in turn affect the diffusion-reaction mechanism and 
consequently determine the properties of the resulting ELK1-GO tubes (Fig. 3f, images). 
 
Underlying molecular mechanism of assembly: ELK1-GO aggregates 
To shed light on this enhanced ELK1-GO interaction at 30 °C, we used small angle neutron scattering 
(SANS) and found that, as expected, ELK1 exhibited an expanded conformation at 4 °C and a collapsed 
aggregated conformation with a 74 nm radius of gyration of the core region at 45 °C (Supplementary 
Figure 10b). Furthermore, at 30 °C, the molecule acquired a conformation that combined both an 
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expanded structure and a collapsed aggregate core, consisting of a 60 nm radius of gyration of the core 
region surrounded by a larger 500 nm radius corona of expanded structures (Supplementary Figure 10b). 
These different conformations were confirmed by cryo-transmission electron microscopy (cryo-TEM) 
(Supplementary Figure 13). On the other hand, GO sheets are known to stack and form lamellae32 in 
aqueous environments. We hypothesised that the disordered nature of ELK1 would facilitate its 
interaction with the supramolecular framework provided by the GO lamella. To test this hypothesis, we 
used SANS to investigate the size and shape of the ELK1-GO aggregates upon co-assembly (Fig. 4a, 
4b, and Supplementary Figure 11a). We found that the scattering profile for the ELK1-GO aggregate 
formed at 30 °C is better fitted with a classical core-shell-bicelle-elliptical model39 with a core 
measuring 7 nm in length, a thick_rim of 22 nm, and a thick_face of 16 nm (Supplementary Figure 11d 
and 11e). According to this model, the core is formed by GO and the shell by ELK1. This core-shell 
conformation was confirmed by confocal microscopy (Fig. 4c). On the other hand, at 4 °C and 45 °C, 
the ELK1-GO aggregates acquire longer cores and thinner shells (Supplementary Figure 11d and 11e), 
which suggests that at these temperatures the GO lamellae are less infiltrated by ELK1 molecules. In 
contrast, at 30 °C, the shorter core of the ELK1-GO aggregates indicates that the GO lamellae are more 
infiltrated by and likely interacting more with the ELK1 (Supplementary Figure 11d and 11e). 
 
Underlying molecular mechanism of assembly: Disorder-to-order transitions to enhance integration  
It is well known that proteins rich in disordered regions change their conformation upon binding to 
other molecules or surfaces40. We hypothesize that the enhanced infiltration by ELK1 within the GO 
lamellae at 30 °C is associated to the disordered nature of the ELK1 and its potential to acquire different 
secondary structures upon interaction with other molecules. We first used FT-IR amide III spectra to 
conduct a quantitative analysis of the ELK1’s secondary structure (Fig. 4d)20,41. At 30 °C and prior to 
co-assembly, ELK1 exhibits a high degree of random coil but also higher amounts of α-helix and lower 
amounts of β-sheet compared to 4 °C and 45 °C (Fig. 4d). Interestingly, upon binding with GO at 30 °C, 
ELK1 maintains its -helix and increases in -sheet (Fig. 4d). These results suggest that as ELK1 
molecules diffuse through the GO lamellae (Fig. 4a, 4b, and 4c) at 30 °C, they bind to and interact with 
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GO maintaining their -helix but increasing their levels of -sheet (Fig. 4d and Supplementary Figure 
10 and 11). It is known that higher levels of -sheet conformation generate denser aggregates42 and that 
α-helix proteins lose entropy and increase the system’s stability by aggregating their helices43. Therefore, 
it is possible that these secondary structures enhance the stability of the ELK1-GO complex and 
consequently lead to a better-defined diffusion barrier at the beginning of the co-assembly process,  
which is known to have an effect on interfacial membrane assembly44. To confirm this, we attempted 
to form tubular structures using the GO-S, which instead lead to a gel-like structure, suggesting the 
formation of a loser and more permeable diffusion barrier (Supplementary Figure 1b).  
 
Biological validation 
The versatility and robustness of the ELK1-GO system offers an exciting possibility to develop complex 
and functional biohybrid devices with a high level of biological relevance by supramolecular processing. 
This potential was assessed by suspending human umbilical vascular endothelial cells (hUVECs) within 
the ELK1 solution prior to co-assembly and growing the tubes described here. Fluorescence microscopy 
revealed that cells were present both within the assembled ELK1-GO membrane as well as inside the 
lumen of the corresponding tubes right after co-assembly (Fig. 2g), which is likely a result of cells being 
either trapped within or adhered to the assembling membrane. Cells were observed to spread and grow 
for at least 7 days both within the membrane and on the lumen of the tubular structures, indicating that 
the material is able to support cell survival and growth. To confirm this finding, cell adhesion and 
proliferation assays were conducted on both sides of ELK1-GO wall of preformed tubes. Remarkably, 
cells were found to adhere and proliferate at similar levels as those growing on tissue culture plastic 
(Fig. 5a and 5b), forming a confluent layer on both sides of the membrane (Fig. 5c). To further assess 
the cell behaviour on the tubular structures, VE-cadherin (CD144) was labelled to observe the 
organization of the intercellular junctions, which are critical for the formation of an intact endothelial 
monolayer45. Confocal images revealed that hUVECs were able to form an integral monolayer on both 
sides of the ELK1-GO membrane (Fig. 5d).  
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This notable cell growth and spread on the co-assembled membranes suggests that the hybrid material 
is cell friendly in vitro. While ELR materials have been shown to support cell growth46,47, GO is known 
to be cytotoxic to endothelial cells in vitro at concentrations higher than 100 ng/mL as a result of plasma 
membrane damage and oxidative stress48. It is important to keep in mind that GO cytotoxicity depends 
on the inherent properties of the specific GO used49. Therefore, we assessed the cytotoxicity of the GO 
used in this study by conducting experiments using hUVECs in media containing varying GO 
concentrations and found that our GO is toxic above 0.001% (10 g/mL) (Supplementary Figure 14). 
However, when co-assembling and growing ELK1-GO tubes in the presence of hUVECs, we used GO 
concentrations that are up to 400x higher than this cytotoxic limit, suggesting that the ELK1-GO 
complex considerably decreases the cytotoxic level of the GO. This decrease may be due to aggregation 
of GO sheets50 and the localization of the ELK1 on the sharp edges of GO sheets51. To investigate 
potential cytotoxicity as a result of membrane degradation, we exposed tubes to cell culture media for 
different time points up to 15 days and used extracts from this media to culture hUVECs. In this case, 
no cytotoxicity was observed for all time-points (Supplementary Figure 15a) compared to hUVECs 
growing in fresh culture media. Furthermore, by physically damaging ELK1-GO tubes suspended in 
culture media using strong agitation and exposing hUVECs to this suspension for 72 hours, cells 
exhibited higher viability compared to cells exposed to GO sheets at similar levels of concentration 
(Supplementary Figure 15b). To further confirm the biocompatibility of the material, we implanted 
ELK1-GO tubes directly on an ex vivo preclinical chick chorioallantoic membrane (CAM) model52 for 
7 days and assessed their cytotoxicity and angiogenesis. Using a Chalkley count analysis, similar 
angiogenesis was observed on both tube-containing samples and control samples (blank model) (Fig. 
5f, Supplementary Figure 16). Furthermore, immunohistochemistry revealed the presence of capillary-
like structures, which in many cases appeared to develop and spread in the vicinity of the ELK1-GO 
membrane (Fig. 5e). These results are in alignment with previous studies demonstrating the angiogenic 
potential of GO48. However, our approach permits this angiogenic potential while enabling the use of 
much higher concentrations of GO. 
 
Discussion 
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We have demonstrated the possibility to exploit multicomponent self-assembly to hierarchically control 
the interactions between a disordered protein and GO and grow hybrid materials and devices with a 
spectrum of new functionalities. The system takes advantage of the inherent properties of both GO and 
ELRs to trigger a diffusion-reaction process that enables disorder-to-order transitions to facilitate GO-
disordered protein interactions, supramolecular integration, and hierarchical assembly. Based on both 
experimental and simulation evidences, we have described the key steps of the underlying molecular 
mechanism and established rules to grow the material and easily assemble functional devices. The 
system exhibits a series of properties that emerge from the synergistic interaction between the two 
components including remarkable stability, access to non-equilibrium for substantial periods of time, 
robustness of assembly, biocompatibility, and bioactivity. We have shown how these properties enable 
its integration with rapid-prototyping techniques to biofabricate functional microfluidic devices by 
directed self-assembly, opening new opportunities for engineering more complex and biologically 
relevant tissue engineered scaffolds, microfluidic systems, or organ-on-a-chip devices. Furthermore, 
our study addresses a major challenge in materials science by demonstrating the possibility to bridge 
the gap between supramolecular design and functional and robust biomedical engineering.  
 
Method 
Chemicals  
4-methylbenzhydrylamine (MBHA) rink amide resin and fluorenylmethyloxycarbonyl (Fmoc)-
protected amino acids were purchased from Merck Millipore. 1-hydroxybenzotriazole (HOBt) hydrate 
was purchased from Cambridge Bioscience. N,N’-diisopropylcarbodiimide (DIC), dimethylformamide 
(DMF), dichloromethane (DCM), piperidine, trifluoroacetic acid (TFA), triisopropylsilane (TIS), 
diethyl ether, acetonitrile (ACN), acetic anhydride and Kaiser Test Kit were purchased from Sigma-
Aldrich and used without further purification. Rhodamine B (>=95%, HPLC grade) and 
paraformaldehyde (95%) were obtained from Sigma-Aldrich. Two kinds of GO (GO-L with product 
number-777676; GO-S with product number-763705) were obtained from Sigma-Aldrich. The GOs’ 
size distribution can be found in Supplementary Fig. 1. Alexa Fluor™ 488 NHS Ester (Succinimidyl 
Ester) was obtained from Thermo Fisher Scientific.  
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Synthesis and characterization of elastin-like recombinamers (ELRs)  
ELK0, ELK1, and ELK3 molecules were provided by TP Nanobiotechnology (Valladolid, Spain). 
Table 1 shows the sequences, molecular weights, and inverse-phase transition temperature (Tt) of the 
ELRs. ELRs were synthesised and purified by E. coli recombinant expression system. The sequence 
and molecular weights of the polymers were verified using amino acid analysis. SDS-PAGE and 
MALDI-TOF SIMS were used to carry out the ELRs characterisation.  
 
Peptide synthesis and purification 
Peptides representative of the single repeat of an individual ELR block were synthesized in a 
microwave-assisted automated peptide synthesizer (Liberty Blue, CEM) using the standard solid phase 
peptide synthesis method and Fmoc-protection chemistry. Because the individual blocks are linked 
together in the ELR molecule through peptide (amide) bonds, synthesized peptides were amidated at 
the C-terminus and acetylated at N-terminus to resemble the continuation of the amide backbone 
character and not introducing any additional charges. MBHA rink amide resin was used as the solid 
support. Amino acid couplings were performed with a mixture of Fmoc-amino acid/HOBt/DIC at a 
molar ratio of 4:4:4, relative to the resin. Fmoc deprotections were performed with 20% (v/v) piperidine 
in DMF for 10 min twice. Once all coupling and deprotection reactions were completed, the N-terminal 
of the peptides were manually capped with 20% acetic anhydride in DMF for 20 min twice. Acetylation 
reaction was monitored with Kaiser test for free amines. Peptides were then cleaved from the resin with 
a mixture of TFA/TIS/H2O at a volume ratio of 95:2.5:2.5 for 2 h with simultaneous removal of side-
chain protecting groups. The cleavage solution was then collected and the excess of TFA removed by 
rotary evaporation. Cold diethyl ether was added to precipitate the peptide product, which was then 
collected, washed again with cold diethyl ether and dried under vacuum overnight. Mass of the crude 
product was analysed via Electrospray Ionization mass spectrometry (ESI-MS, Agilent).  
 
Purification of the peptides was performed in an AutoPurification System (Waters) using a preparative 
reverse-phase C18 column (XBridge, 130 Å, 5 µM, 30 x 150 mm, Waters) and H2O/ACN (0.1% TFA) 
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as mobile phase. Fractions containing the peptides were automatically collected when their exact mass 
was detected in the SQ Mass Detector (Waters). The collected peptide fractions were lyophilized and 
stored at -20 ˚C until further use.  
 
Mass confirmation for all peptides was performed via ESI-MS and their purity confirmation analysed 
in an Alliance HPLC system (Waters) equipped with an analytical reverse-phase C18 column (XBridge, 
130 Å, 3.5 µM, 4.6 x 150 mm, Waters) and monitored at 220 nm . 
  
Sample preparation (ELRs-GO system)  
Aqueous suspension of GO (0.1 wt%, 100 μL) was added to a well of 96-well tissue culture plastic 
(TCP) and aqueous solution of the ELRs (2 wt%, 18 μL) was slowly injected into the suspension of GO. 
The tip of the pipette was allowed to make contact with the bottom of the well before releasing the 
ELRs solution vertically at a constant speed. All samples were prepared in MilliQ water.  
 
Temperature-controlled spectrophotometry 
The thermo-responsive behaviour of ELK1 at certain concentration (2 wt%) and pH 8 was determined 
on a temperature-controlled UV-visible spectrophotometer (Agilent Technologies). ELR samples (2 
wt%) were prepared in MilliQ water and the pH of the solutions was adjusted with HCl (0.5 M) and 
NH4OH (1.0 M) prior to heating at 1° C/min ramping rate. Absorbance of the samples was obtained at 
λ = 350 nm.  
 
Zeta potential (ζ) 
In order to optimize the formation of the ELK1-GO system, the zeta potential of both ELK1 and GO 
was measured on Zetasizer (Nano-ZS ZEN 3600, Malvern Instruments, UK) at 30 °C under various pH 
conditions. The concentration of ELK1 and GO used for the measurements is 0.025 wt% and 0.00125 
wt%, respectively. The pH values of the two component solutions were adjusted using 0.5 M HCl (at 
most 3 μL into 1 mL ELK1 or GO solution) and 1.0 M NH4OH (at most 2 μL into 1 mL ELK1 or GO 
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solution) and the samples were equilibrated for 10 min at the set temperature prior to the measurement 
of zeta potential. 
 
Dynamic light scattering (DLS) 
DLS was performed to measure changes in the particle size of ELK1-GO aggregates at 4 °C (below 
ELK1’s Tt), 30 °C (at the Tt), and 45 °C (above the Tt). The ELK1 and GO were dissolved in MilliQ 
water at the concentrations of 0.2% and 0.01% separately. The two solutions were mixed in a 1:1 ratio 
and the particle sizes were measured using Zetasizer (Nano-ZS ZEN 3600, Malvern Instruments, UK). 
Samples were equilibrated for 10 min at the desired temperature before measurements. 
 
Fluorescence emission 
Fluorescence emission was measured on LS 55 spectrofluorometer (Perkin Elmer). The aqueous 
solution of GO (2.5 x10-3 wt%, 1.5 mL) and the solution of various concentrations of ELRs (1.5 mL) 
were mixed in a 10 mm path length cuvette at 30 °C.  The excitation and emission slits were set at 10 
nm. The GO was excited at 255 nm and the emission spectra were collected between 300-700 nm (200 
nm/min). The fluorescence emission intensity was recorded at 518 nm. The data were fitted into the 
Benesi-Hildebrand equation1 (1) in order to determine the association/binding constant (Ka) between 
GO and ELRs.   
 
                                          1/∆I = 1/∆Imax + (1/K[C]) (1/∆Imax)                                                       (1) 
 
Where [C] is the concentration of ELRs, ∆I = I-Imin and ∆Imax = Imax-Imin, where Imin, I, and Imax 
are the emission intensities of GO considered in the absence of ELRs, at an intermediate ELRs 
concentration and a concentration of complete saturation, respectively. From the plot of (Imax-Imin)/ 
(I-Imin) against [C]-1 for GO, the value of Ka was determined from the slope.  
   
Circular dichroism (CD) 
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Variable temperature CD (VT-CD) measurements were carried out on Chirascan™ CD Spectrometer 
(Applied Photophysic Limited, U.K.) from 10 °C to 40 °C. The solutions of ELK1 (0.01% wt) were 
prepared in MilliQ water and incubated at each temperature for 10 min before measurements. A quartz 
cuvette with 0.1 cm path length was used for the measurements and CD spectra were obtained by signal 
integrating 10 scans, from 190 to 260 nm at speed of 50 nm/min. Data were processed by a simple 
moving average and smoothing method. 
 
Fourier transform infra-red spectroscopy (FT-IR) 
FTIR analysis was conducted on FTIR spectrometer GX (PerkinElmer®, Waltham, MA, USA). A 
solution of ELK1 (2 wt%) in a mixture of D2O and H2O (75/25 v/v) and the preformed ELK1-GO 
membranes prepared in the same solution were properly secured over the IR window before scanning. 
All samples were incubated and formed at 4, 30, and 45 °C for 10 min before measurements. The 
program was set to take the average of 160 scans at a resolution of 2 cm-1 after subtracting the 
background and spectra were obtained at wavenumber 4000 cm-1 to 600 cm-1 with respect to the 
absorbance for all samples. In order to quantitatively determine the maximum absorption intensity 
corresponding to various secondary structures of the ELRs (α-helix, β-sheets, β-turns, and random coils) 
amide III region (1350 – 1200 cm−1) was analysed using second derivative of a Guassian and Lorentian 
curve fittings. The second derivative fingerprints for the secondary structures of the ELRs are as follows: 
1220 – 1250 cm−1 for β-sheets, 1250 – 1270 cm−1 for random coils, 1270 – 1295 cm−1 for β-turns, 
1295 – 1330 cm−1 for α-helix, as previously suggested by Cai, S. et al. 
 
Scanning electron microscopy (SEM) and wavelength-dispersive spectroscopy (WDS) 
The microstructures of ELRs-GO and ELK1-GO membranes co-cultured with HUVECs were examined 
by SEM. ELK1-GO membranes with HUVECs were fixed with 4% paraformaldehyde in MilliQ water 
for 20 min before dehydration while ELRs-GO membranes were dehydrated directly using increasing 
concentrations of ethanol (20, 50, 70, 90, 96, and 100%). All samples were subjected to critical point 
drying (K850, Quorum Technologies, UK) prior imaging. The SEM micrographs were captured on 
Inspect F50 (FEI Comp, the Netherlands) after sputter-coating with gold (10 nm thick). WDS elemental 
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analyses were performed to study the molecular composition of both the inner and outer surfaces of the 
ELK1-GO membranes. Quantitative Nitrogen elements (nitrogen exists in ELRs not in GO.) were also 
analysed using the Inspect F50 (FEI Comp, the Netherlands). All samples consisting only ELRs or GO 
were prepared for SEM imaging without a prior cross-linking process. 
 
Cryo-Transmission electron microscopy (Cryo-TEM) 
The ELK1 solutions were prepared at 2 wt% in MilliQ water. Grids were vitrified using the Vitrobot 
MK IV. The Vitrobot chamber was equilibrated to the desired temperature (4 °C, 30 °C or 45 °C), at 
95% relative humidity. Quantifoil R 1.2/1.3 grids were glow discharged in air using the Quorum 
GloQube® for 60 s, 40 mA. Grid tweezers, grid and pipette tips were preheated to protein aggregate 
temperature before using. 3 μL of sample was applied to the grid, blotted for 5 or 6 seconds with a blot 
force of 6. Cryo-TEM imaging was performed on a Titan Krios microscope (Thermo Fisher Scientific, 
US) operating at 300 kV, using a Falcon III direct electron detector.  
 
Confocal microscopy 
The interaction and localisation of ELK1 and GO was probed using laser scanning confocal and 
multiphoton microscopy (TCS SP2, Leica Microsystems, Germany). ELK1 (10-6 wt%) was dissolved 
in an aqueous solution of Alexa Fluor™ 488 NHS Ester (2 w%t) and GO were diluted to 10-6 wt% with 
an aqueous solution of Rhodamine (0.1%). All solutions were incubated for 20 min at 30 °C and 
protected from light. The tubes were fabricated with 50 μL GO-Rhodamine solution and 10 μL ELK1-
Alexa Fluor solution in a 96-well Petri dish as previously described. Images were acquired at laser 
wavelengths of 488 nm and 543 nm which correspond to the excitation wavelength of Alexa Fluor and 
rhodamine, respectively. Images were further processed using ImageJ. 
 
Small-angle neutron scattering (SANS)  
The GO suspension and ELK1 were dissolved in H2O/D2O (25%/75%) respectively with 0.1% and 2%. 
Small-angle neutron scattering (SANS) measurements were performed on the fixed-geometry, time-of-
flight LARMOR diffractometer (ISIS Neutron and Muon Source, Oxfordshire, UK). A white beam of 
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radiation with neutron wavelengths spanning 2.2 to 10 Å was enabled access to Q [Q = 4πsin (θ/2)/λ] 
range of 0.004 to 0.4 Å−1 with a fixed-sample detector distance of 4.1 m. Solutions (0.4 mL) of 
individual components were contained in 1 mm path length UV spectrophotometer grade quartz 
cuvettes (Hellman) while the composite materials were prepared by mixing equal volume (0.2 mL) of 
both components in a demountable 1 mm path length cuvettes. The cuvettes were mounted in aluminium 
holders on top of an enclosed, computer-controlled sample chamber at 30 °C. For the variable 
temperatures experiment (especially those involving ELK1 at 4, 30 and 45 °C), a thermostatted 
circulating water bath was fitted with the sample chamber. Time taken for each measurement was 
approximately 30 min. All scattering data were normalized for the sample transmission, the 
backgrounds was corrected using a quartz cell filled with D2O or H2O/ D2O (25%/75%) and the 
linearity and efficiency of the detector response was corrected using the instrument-specific software. 
 
In the present SANS experiments, we consider that the scattering length density (SLD) of the H2O/ 
D2O (25%/75%) is a volume fraction weighted average of the SLDs of the individual components. 
Given the SLDs for H2O and D2O are -5.6x10-7 Å-1 and 6.3 x10-6 Å-1, we determined the SLD of the 
H2O/ D2O (25%/75%) is 4.653 x10-6 Å-1. The neutron scattering length densities for the GO3, H2O/ 
D2O, and ELK1 are summarized in Supplementary Fig. 5IIc. 
 
Cell culture 
Human Umbilical Vein Endothelial Cells (hUVECs) (Lonza, Isolated in EGM™-2 Media, C2519A) 
were cultured in EGM™-2 Media (Lonza, CC-3156& CC-4176). The medium was changed every 3 
days until the cells reached 80% confluency. hUVECs between passage 2 and 4 were used for 
experiments. The tubes were first washed three times with PBS 8 h after assembly and sterilized with 
UV for 45 min. Then each tube was placed in a well of 48-well cell culture plate with inner or outer 
side facing up. The EGM™-2 Media (500 μL) containing 50,000 cells was added to each well 
containing ELK1-GO membranes, coated with ELRs solution (18 μL, 2 wt%), GO (20 μL, 0.1 wt% 
GO) or on tissue culture plastic (TCP – positive control). The coated wells were incubated for 8 hrs 
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prior to cell seeding. The cells were incubated at 37 °C and 5% CO2 for different time points for all 
tests (protocol shown below). 
 
Cell viability and proliferation assay and Cytotoxicity Assay  
The effect of ELK1-GO membranes on hUVECs viability and proliferation using the CellTiter 96® 
Aqueous One Solution Cell Proliferation Assay (Promega, Southampton, UK). Cells were seeded at a 
concentration of 50,000 cells/well in 48-well plates. After incubation for 24 hrs, 1 d, 3 d, 5 d, 7 d, cell 
culture medium was aspirated and 500 μL of EGM™-2 Media containing 10% MTS reagent was added 
to each well. Plates were subsequently incubated for 3 hrs at 37 °C and the absorbance was read at 490 
nm using Infinite F50 plate reader (Tecan, Switzerland). Five replicates of each condition were 
performed with each assay repeated in triplicate. The cell viability was determined as a percentage of 
control cell viability and proliferation. 
 
A LIVE-DEAD® Cytotoxicity Assay Kit (Invitrogen, USA) was used to measure the viability of 
hUVECs seeded on the ELK1-GO membranes. Five replicates of each condition were performed with 
each assay repeated in triplicate. A stock solution containing calcein AM (1 μM) and ethidium 
homodimer (2 μM) in PBS was prepared according to the assay instructions, and 200 μL of stock 
solution was added to each well. Fluorescence images were captured on laser scanning confocal and 
multiphoton microscopy (TCS SP2, Leica Microsystems, Germany). Viable cells were stained green 
with calcein AM (ex 495nm, em 530 ± 12.5 nm), while dead cells red with ethidium homodimer (ex 
528nm, em 645 ± 20 nm).  
 
GFP-hUVECs (Fisher scientific, Angio Proteomie GFP-hUVECs, NC0601093, USA) were used to 
assess the cytotoxicity of GO by culturing >95% confluent GFP-hUVECs in media containing varying 
GO concentrations (0, 0.001, 0.0025, 0.005, 0.01, 0.25, 0.05 and 0.1%) and cultured for 48 h. 
Fluorescent images were taken at 1, 8, 24 and 48 hr to assess the cytotoxicity by morphology and 
confluency analysis. 
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GFP-hUVECs were also used to assess the potential cytotoxicity of ELK1-GO degradation products 
(extracts). We exposed 1 tube fabricated by 100 µL 0.1% GO and 18 µL 2% ELK1 to 1 mL cell culture 
media for different periods of time s (1, 3, 6, 9, 12 and 15 days) and used the extracts from this media 
to culture >95% confluent GFP-hUVECs for 7 days. Fluorescent images were taken at day 1 and day 7 
to assess the cytotoxicity by morphology and confluency. To further assess the potential physical 
degradation of ELK1-GO, physically damaged ELK1-GO tubes using strong agitation were suspended 
in culture media and exposing >95% confluent GFP-hUVECs to this suspension for 72 hours. 
Fluorescent images were taken to assess the cytotoxicity. 
 
Immunofluorescence staining  
hUVECs on the ELK1-GO membrane were fixed with 4% paraformaldehyde (Sigma, USA), washed 
and permeabilized with 0.5% Triton X-100 (Sigma, USA), and then rinsed 3 times with PBS. 
Nonspecific binding sites were blocked by PBS containing 1% BSA. The CD144 marker was labelled 
by incubating the cells at room temperature for 1 hr with anti-rabbit monoclonal VE-cadherin primary 
antibody (1:400, ab33168, Abcam, UK). Cells were then washed and incubated for 50 min at room 
temperature in Alexa 488 conjugated anti-Rabbit IgG as Secondary Antibody (1:1000, R37116, 
Invitrogen, USA). The stained ELK1-GO membranes were then transferred to slides and visualized on 
a laser scanning confocal and multiphoton microscopy (TCS SP2, Leica Microsystems, Germany) 
utilising x10 and x40 objectives.   
 
Chick chorioallantoic membrane (CAM) assay 
Fertilised chick eggs (Gallus domesticus) were kept in a hatchmaster (Brinsea, UK) incubated at 37.5 
ºC and humidified with rotation. 12 (6 per group: blank control group and ELK1-GO group) day 1 
fertilised eggs were maintained within the hatchmaster. After candling the egg to determine if the egg 
is fertilised a window was created at day 7 under sterile conditions. A window was created by scoring 
with a scalpel and an approximately 6 mm square opening created in the outer shell of the egg. The 
membrane was removed from the underlying CAM vascular membrane. ELK1-GO tube samples were 
inserted into the window and onto the chorioallantoic membrane. Eggs were transferred to a 
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Hatchmaster incubator and incubated for a duration of 8 days at 37.5 °C 60% humidity without rotation. 
All procedures were performed in accordance with ethical approval and in accordance with the Animal 
(Scientific Procedures) Act 1986, UK (Project License number P3E01C456). After 8 days of the CAM 
culture the implanted samples were harvested. 
 
Immunohistology staining  
Slides were first deparaffinized by washing in 2 changes of xylene (Sigma, UK) and graded ethanol 
baths (absolute ethanol, 90%, 70%). Antigen retrieval was performed to unmask the antigenic epitope 
of the tissue sample by boiling the deparaffinized sections in citrate buffer (Vector laboratories, UK) at 
pH 6.0. Endogenous peroxidase activity was blocked by incubating sections in 3% H2O2 solution 
(Sigma, UK) in PBS at room temperature for 10 min followed by 2 rinses in PBS. To reduce background 
staining and any other immunostaining application, the samples were incubated with normal goat serum 
(5% in PBS, Vector laboratories, UK) to block nonspecific binding sites in a humidified chamber at 
room temperature for 1 hour before staining. After draining the blocking buffer, 100 µL of diluted 
primary anti-α-SMA antibody (1:500, ab5694, Abcam, UK) was added to the sections on the slides and 
incubated in a humidified chamber at room temperature for 1 hr, after which the slides were washed 
twice in PBS. Then, 100 µL of ready-to-use biotinylated anti-mouse/rabbit IgG secondary antibody 
(Ready-to-use, PK-7200, Vector laboratories, UK) was applied to the sections on the slides and 
incubated in a humidified chamber at room temperature for 30 min with the slides washed in PBS after 
that. Amplification of antigen was achieved using an Elite® ABC-HRP Kit (PK-7200, Vector 
Laboratories, UK) and positive staining was visualized by incubating in a peroxidase substrate solution 
using a DAB Peroxidase (HRP) Substrate Kit (PK-7200, Vector laboratories, UK).     
 
Analysis of goldner's trichrome staining by Chalkley count 
The Chalkley point-overlap morphometric technique is a relative area estimate method to measure the 
abundance of microvessels in an immunohistochemical sample. A “Chalkley point array graticule” was 
used to fit onto the eyepiece of a microscope. This graticule consists of a grid that contain 25 random 
dots which can be rotated 360°. An observer can overlay these dots over structures that have stained 
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positively with goldner's trichrome. The rotational position with the most dots that land on positively 
stained structures is described as the “Chalkley count” and samples have higher counts are considered 
to contain a greater abundance of blood vessels. A blank histological slide sample and three ELK1-GO 
histological slide samples were scoring by this technique.  
 
Co-assembly of ELK1-GO-hUVECs  
EGM™-2 Media containing hUVECs (105 cells/ml) was used to dissolved the ELK1 (2 wt%). The 
ELK1-hUVECs media (10 μL) was added into GO (50 μL, 0.4 wt%) solution to make a tube as 
previously described. All these co-assembled ELK1-GO-hUVECs tubes were incubated at 37 °C, 5% 
CO2 for 24 h, 1 d, 3 d, 5 d prior to LIVE-DEAD® cytotoxicity Assay and SEM procedures as described 
previously. 
 
3-D printing of ELR/GO materials 
A PAM2 system (Centro Piaggio, Pisa University, Italy) was applied for the 3-D printing of ELK1-GO 
materials. Blue food dye (5 μL) was added into aqueous solution of ELK1 (2 mL, 2 wt%) to make the 
printing procedure visible. For fabricating the different shapes of structures and the 60 μm diameter 
small tube, a 65 μm diameter glass tube tip was used as nozzle to release the solution of the ELK1 and 
the dye under 4 kPa pressure at a range of speed between 10 mm/s and 18 mm/s. The printing nozzle is 
merged in a container with 0.1% GO MilliQ water solution. All the 3-D pathway was controlled by the 
Repetier software. A peristaltic pump was used to perfuse 1v/v green food dye in MilliQ water. For the 
vertical tube, the perfusion speed is from 4.7 mL/min to 8.3 mL/min. For other structures, the perfusion 
speed was 2 mL/min. 
 
Statistical analysis 
GraphPad Prism 5 was applied for data analysis. Student T-test statistical analysis was applied for all 
the measured data. 
 
Data availability.  
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The data that support the findings of this study are available from the authors on reasonable request, see 
author contributions for specific data sets. 
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Figure Legends 
Figure 1. Molecular building blocks and rationale for co-assembly. a. Table summarizes the key 
information of the three elastin-like recombinamers (ELRs) used in the study comprising similar 
molecular weight but different levels of hydrophobicity (VPGIG) and positive charge (VPGKG). b. 
Illustrations of the molecular structure of a GO sheet and the supramolecular organisation of ELK1 at 
its Tt (30 °C) indicating both the charged (red and green) and hydrophobic (brown) segments. c. 
Schematic of the proposed mechanism of formation illustrating the molecular and supramolecular 
conformation of the GO and ELK1 before and after co-assembly at the ELK1’s transition temperature 
(Tt) as well as their interaction for membrane formation.  
 
Figure 2. Co-assembly, structure, properties, and biofabrication of the ELK1-GO system. Time-
lapse images illustrate the dynamic properties of the ELK1-GO membrane first a. (top) forming a closed 
sac when a drop of ELK1 solution is immersed in a larger GO solution, a. (bottom) opening upon 
touching an interface within the first seconds of formation. b. The membrane exhibits a multi-layered 
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architecture of about 50 m thick comprising aligned GO sheets throughout (birefringence inset) 
interacting with ELK1 molecules (fluorescence image, green: ELK1, red: GO), c. which are observed 
to decrease in concentration from the inside to the outside as evidenced by wavelength-dispersive 
spectroscopy (WDS). Only ELK1 comprises nitrogen in its molecular structure. ±s.d. for n=3. *p< 0.05. 
T-test. d. The system enables growing the membranes into longer tubes on demand by displacing an 
interface. e. The robustness of the system enables formation of capillaries down to about 50 m in 
internal diameter with 10 m thick walls, f. bridging of surfaces simply by touching two interfaces 
while injecting one solution into the other, and g. co-assembling in salt solutions, opening the possibility 
to embed cells (green identified by white arrows) within the membrane (outlined by dashed lines) as 
the tubes are formed. The images are taken after 24 h of culture and correspond to a live (green)/dead 
(red) assay. Scanning electron micrographs of cells embedded within layers of GO (top) and a cross-
section of the ELK1-GO membrane comprising cells within different layers (bottom). h, i, j, k, l. Images 
demonstrate the versatility of the co-assembly system by incorporating it with 3D printing to fabricate 
well-defined fluidic devices consisting of high-aspect ratio tubular structures (h) of different internal 
diameters and comprising curves, angles of different sizes, and bifurcations (h, i, l) capable of 
withstanding flow within a few minutes of formation (j, k).  
 
Figure 3. Molecular interaction, composition, and mechanical properties of ELR-GO. a. Binding 
constants (Ka) for the different ELR-GO combinations calculated by a Benesi-Hildebrand Equation 
based on fluorescence emission titration of a mixture of GO (2.5x10-3 wt%) in MilliQ water solution 
and increasing concentrations of ELRs revealing higher Ka for ELK1-GO compared to ELK0-GO and 
ELK3-GO. b. Table illustrating the role of building-block concentration ratio on the formation of 
ELK1-GO tubes. c. Nanotensile test results reveal that the strength, the strain at break, and the toughness 
modulus increased on tubes formed with increasing concentrations of GO but the elastic modulus was 
highest on tubes made with medium level (0.10%) GO compared to lower (0.05%) and higher (0.15%) 
amounts based on Weibull statistical distribution. d. Table illustrating the role of pH and ζ on the 
formation of the ELK1-GO tubes and their respective geometry. e. Representative confocal microscopy 
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qualitatively depicting the interface between ELK1 (green) and GO (red) during tube formation with 
different levels of definition as characterized in d. f. Red line of the graph shows the turbidity changes 
of an ELK1 (2 wt%) solution in MilliQ water while inserted images depict the definition of tubes formed 
at specific temperatures. g. Dynamic light scattering (DLS) revealing the presence of larger ELK1-GO 
aggregates at 30 °C compared to 4 °C and 45 °C. Error bars represent ±s.d. for n=3. *p< 0.05. One-
way ANOVA. 
 
Figure 4. Supramolecular assembly of the ELK1-GO system. a. Small-angle neutron scattering 
(SANS) patterns demonstrating a resulting uniform microstructure formed when co-assembling ELK1-
GO. Between the middle-q region (ca 0.007-0.04 Å-1), the ELK1-GO structure (yellow triangle) 
exhibits a characteristic scattering peak associated with pure ELK1 (green square) and GO (red 
circle) at 30 °C, confirming the formation of a new order structure different from the individual 
components. b. The classical core-shell-bicelle-elliptical model that was fitted to the ELK1-GO 
microstructure as measured by SANS at 30 °C (green: ELK1, brown: GO). c. Confocal microscopy 
(green: ELK1, red: GO) corroborating the interaction between the ELK1 and the GO lamellae (inset 
depicts the top view of the ELK1-GO structure). d. FT-IR calculation of secondary structure depicting 
the change and transition of conformation of the ELK1 molecule before and after binding with GO. At 
30 °C and before binding with GO, ELK1 exhibits higher -helix than at 4 °C and 45 °C, which is 
maintained after binding with GO and is complemented with an increase in -sheet.  
 
Figure 5. In vitro biocompatibility and bioactivity of the ELK1-GO membrane. a. The applicability 
of the material was assessed by an MTS assay to test cell viability and proliferation of hUVECS on both 
sides of the ELK1-GO membrane. The results revealed that cell viability and proliferation on ELK1-
GO materials are at least similar to those of cells growing on tissue culture plastic (TCP) for 7 days. 
Error bars represent ±s.d. for n=3. *p< 0.05. Two-way ANOVA. b. Live (green)/dead (red) assay 
confirmed the proliferation of hUVECs. c. Scanning electron micrographs demonstrate the formation 
of an integral endothelial layer on both sides of the ELK1-GO membrane. d. VE-cadherin (CD144) was 
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labelled to observe the organization of the intercellular junctions and revealed that cells exhibited strong 
intercellular junction staining, also suggesting the formation of an integral endothelial layer on the 
ELK1-GO membrane. e. Histological sections of the ELK1-GO tube implants within a chick 
chorioallantoic membrane (CAM) model for 7 days highlighting alpha smooth muscle actin (α-SMA, 
pink), and cell nuclei (blue). The results revealed endothelial cells forming capillary-like structures 
surrounding the ELK1-GO tubes (yellow arrows). f. Chalkley count analysis showing a slightly higher 
level of angiogenesis on tube-containing samples compared to control (blank model) samples. ± s.d. for 
n=3. *p< 0.05. One-way ANOVA. NS= no significance. 
 
